BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10745005)

  • 1. The crystal structure of shiga toxin type 2 with bound disaccharide guides the design of a heterobifunctional toxin inhibitor.
    Jacobson JM; Yin J; Kitov PI; Mulvey G; Griener TP; James MN; Armstrong G; Bundle DR
    J Biol Chem; 2014 Jan; 289(2):885-94. PubMed ID: 24225957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid reorganization induced by Shiga toxin clustering on planar membranes.
    Windschiegl B; Orth A; Römer W; Berland L; Stechmann B; Bassereau P; Johannes L; Steinem C
    PLoS One; 2009 Jul; 4(7):e6238. PubMed ID: 19606209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.
    Fraser ME; Fujinaga M; Cherney MM; Melton-Celsa AR; Twiddy EM; O'Brien AD; James MN
    J Biol Chem; 2004 Jun; 279(26):27511-7. PubMed ID: 15075327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C500 variants conveying complete mucosal immunity against fatal infections of pigs with
    Liu G; Li C; Liao S; Guo A; Wu B; Chen H
    Front Microbiol; 2023; 14():1210358. PubMed ID: 37779705
    [No Abstract]   [Full Text] [Related]  

  • 5. Shiga Toxin, Stx2e, Influences the Activity of Porcine Lymphocytes In Vitro.
    Sperling D; Stepanova H; Smits H; Diesing AK; Faldyna M
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and Functional Characterization of Stx2k, a New Subtype of Shiga Toxin 2.
    Hughes AC; Zhang Y; Bai X; Xiong Y; Wang Y; Yang X; Xu Q; He X
    Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31861375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcal Adhesin P (SadP) contributes to Streptococcus suis adhesion to the human intestinal epithelium.
    Ferrando ML; Willemse N; Zaccaria E; Pannekoek Y; van der Ende A; Schultsz C
    PLoS One; 2017; 12(4):e0175639. PubMed ID: 28407026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of Shiga toxin Stx2e neutralization by a single-domain antibody targeting the cell receptor-binding domain.
    Lo AW; Moonens K; De Kerpel M; Brys L; Pardon E; Remaut H; De Greve H
    J Biol Chem; 2014 Sep; 289(36):25374-81. PubMed ID: 25053417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolipid binding preferences of Shiga toxin variants.
    Karve SS; Weiss AA
    PLoS One; 2014; 9(7):e101173. PubMed ID: 24983355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of an Enterobacter cloacae strain producing a novel subtype of Shiga toxin type 1.
    Probert WS; McQuaid C; Schrader K
    J Clin Microbiol; 2014 Jul; 52(7):2346-51. PubMed ID: 24759708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entry and killing of Tetrahymena thermophila by bacterially produced Shiga toxin.
    Stolfa G; Koudelka GB
    mBio; 2012 Dec; 4(1):e00416-12. PubMed ID: 23269826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin binding to glycolipids and glycans.
    Gallegos KM; Conrady DG; Karve SS; Gunasekera TS; Herr AB; Weiss AA
    PLoS One; 2012; 7(2):e30368. PubMed ID: 22348006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.
    Liu F; Huang J; Sadler JE
    Blood; 2011 Sep; 118(12):3392-8. PubMed ID: 21816831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of differential B-pentamer stability of Shiga toxins 1 and 2.
    Conrady DG; Flagler MJ; Friedmann DR; Vander Wielen BD; Kovall RA; Weiss AA; Herr AB
    PLoS One; 2010 Dec; 5(12):e15153. PubMed ID: 21203383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin subtypes display dramatic differences in potency.
    Fuller CA; Pellino CA; Flagler MJ; Strasser JE; Weiss AA
    Infect Immun; 2011 Mar; 79(3):1329-37. PubMed ID: 21199911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.
    Strauch E; Schaudinn C; Beutin L
    Infect Immun; 2004 Dec; 72(12):7030-9. PubMed ID: 15557626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2.
    Gamage SD; McGannon CM; Weiss AA
    J Bacteriol; 2004 Aug; 186(16):5506-12. PubMed ID: 15292153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Shiga toxins, intimin and enterohemolysin in Escherichia coli strains isolated from children in eastern Slovakia.
    Liptáková A; Siegfried L; Podracká L; Sabol M; Sehnálková H; Bogyiová E; Rosocha J; Kmetová M; Kerestesová H; Kotulová D
    Folia Microbiol (Praha); 2002; 47(2):185-8. PubMed ID: 12058400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity.
    Ling H; Pannu NS; Boodhoo A; Armstrong GD; Clark CG; Brunton JL; Read RJ
    Structure; 2000 Mar; 8(3):253-64. PubMed ID: 10745005
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.